Revascularization During Cardiac Arrest While Receiving Extracorporeal Life Support in Patients With Acute Myocardial

Takahiro Nakashima1,2, Marina Arai3, Akihiko Inoue4

  • 1Department of Emergency Medicine and The Harry Max Weil Institute for Critical Care Research and InnovationUniversity of Michigan, Ann Arbor, Michigan, USA.

JACC. Advances
|January 6, 2025
PubMed

Insights

Extracorporeal cardiopulmonary resuscitation (ECPR) enables primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) patients with refractory out-of-hospital cardiac arrest (OHCA). Survival to discharge was achieved by 21.1% of these patients, with key predictors identified.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Intensive Care Medicine

Background:

  • Extracorporeal cardiopulmonary resuscitation (ECPR) has expanded treatment options for refractory out-of-hospital cardiac arrest (OHCA) due to acute myocardial infarction (AMI).
  • ECPR now allows primary percutaneous coronary intervention (PCI) in patients previously ineligible due to refractory cardiac arrest.

Purpose of the Study:

  • To characterize patients with OHCA secondary to AMI undergoing primary PCI during refractory cardiac arrest despite ECPR.
  • To clarify the outcomes and identify predictors of survival in this patient cohort.

Main Methods:

  • A multicenter registry in Japan identified patients (≥18 years) with AMI and OHCA who underwent PCI with ECPR between 2013-2018.
  • In-hospital mortality was the primary outcome; predictors of survival to discharge were assessed using mixed-effects logistic regression.

Main Results:

  • Of 671 patients, 251 (37%) had refractory cardiac arrest despite ECPR and underwent primary PCI.
  • Following reperfusion, 64.9% achieved sustained return of spontaneous circulation (ROSC), 21.1% survived to discharge, and 10.4% had favorable neurological status.
  • Predictors of survival included intermittent prehospital ROSC, shorter time to ECPR initiation, and postprocedural TIMI flow grade 3.

Conclusions:

  • One-third of AMI patients with refractory OHCA treated with ECPR did not achieve sustained ROSC before PCI.
  • Two-thirds achieved sustained ROSC post-reperfusion, with one-fifth surviving to hospital discharge.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...